269 related articles for article (PubMed ID: 12775319)
21. Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris.
Hashizume H; Ito T; Yagi H; Takigawa M; Kageyama H; Furukawa F; Hata M; Shirahama S; Tanaka M; Higashishiba T; Machida H; Tsushima T; Matsushita K
J Dermatol; 2007 Jul; 34(7):430-4. PubMed ID: 17584318
[TBL] [Abstract][Full Text] [Related]
22. Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis.
Lago E; Carneiro S; Cuzzi T; Magalhães G; Cássia F; Pessanha F; Ramos-e-Silva M
J Cutan Pathol; 2007 Jan; 34(1):15-21. PubMed ID: 17214849
[TBL] [Abstract][Full Text] [Related]
23. Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris.
Abe M; Ishibuchi H; Syuto T; Sogabe Y; Yokoyama Y; Ishikawa O
J Dermatol; 2007 May; 34(5):290-3. PubMed ID: 17408436
[TBL] [Abstract][Full Text] [Related]
24. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A.
Schopf RE; Hultsch T; Lotz J; Bräutigam M
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435
[TBL] [Abstract][Full Text] [Related]
25. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
[No Abstract] [Full Text] [Related]
26. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
Atakan N; Erdem C
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of a fixed-dose cyclosporin microemulsion (100 mg) for the treatment of psoriasis.
Shintani Y; Kaneko N; Furuhashi T; Saito C; Morita A
J Dermatol; 2011 Oct; 38(10):966-72. PubMed ID: 21545506
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA
N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.
Faerber L; Braeutigam M; Weidinger G; Mrowietz U; Christophers E; Schulze HJ; Mahrle G; Meffert H; Drechsler S
Am J Clin Dermatol; 2001; 2(1):41-7. PubMed ID: 11702620
[TBL] [Abstract][Full Text] [Related]
30. A study of the use of drugs in patients suffering from psoriasis and their impact on quality of life.
Karamata VV; Gandhi AM; Patel PP; Sutaria A; Desai MK
Indian J Pharmacol; 2017; 49(1):84-88. PubMed ID: 28458428
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines.
Altomare G; Ayala F; Bardazzi F; Bellia G; Chimenti S; Colombo D; Flori ML; Girolomoni G; Micali G; Parodi A; Peris K; Vena GA
G Ital Dermatol Venereol; 2016 Aug; 151(4):432-5. PubMed ID: 25786483
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases.
Leonardi S; Marchese G; Rotolo N; Miraglia Del Giudice M; La Rosa M
Minerva Pediatr; 2004 Apr; 56(2):231-7. PubMed ID: 15249910
[TBL] [Abstract][Full Text] [Related]
33. A case of generalized pustular psoriasis treated with topical tacrolimus.
Nagao K; Ishiko A; Yokoyama T; Tanikawa A; Amagai M
Arch Dermatol; 2003 Sep; 139(9):1219. PubMed ID: 12975175
[No Abstract] [Full Text] [Related]
34. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
[TBL] [Abstract][Full Text] [Related]
36. A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses.
Bourke JF; Berth-Jones J; Holder J; Graham-Brown RA
Br J Dermatol; 1996 Apr; 134(4):777-9. PubMed ID: 8733391
[TBL] [Abstract][Full Text] [Related]
37. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
Katz HI
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
[TBL] [Abstract][Full Text] [Related]
38. The use of cyclosporin in a child with generalized pustular psoriasis.
Alli N; Güngör E; Karakayali G; Lenk N; Artüz F
Br J Dermatol; 1998 Oct; 139(4):754-5. PubMed ID: 9892934
[No Abstract] [Full Text] [Related]
39. A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis.
Yoon HS; Youn JI
J Dermatolog Treat; 2007; 18(5):286-90. PubMed ID: 17852632
[TBL] [Abstract][Full Text] [Related]
40. Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study.
Cannavò SP; Guarneri F; Vaccaro M; Borgia F; Guarneri B
Dermatology; 2003; 206(2):153-6. PubMed ID: 12592084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
